Indication

B-cell acute lymphoblastic leukemia

B-cell acute lymphoblastic leukemia is an aggressive hematologic malignancy characterized by the uncontrolled proliferation and accumulation of immature B-cell progenitor lymphoblasts within the bone marrow and peripheral blood. Read more about B-cell acute lymphoblastic leukemia

7 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common B-cell acute lymphoblastic leukemia therapies.

Showing 1–7 of 7 drugs

BLINCYTO (blinatumomab)

ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER·B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA·+1
AMGEN

BLINCYTO (blinatumomab)

ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER·B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA·+1
AMGEN

BLINCYTO (blinatumomab)

ANTINEOPLASTIC - IMMUNOTHERAPY, T-CELL ENGAGER·B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA·+1
AMGEN

KYMRIAH (tisagenlecleucel)

ANTINEOPLASTIC - CAR-T/TCR-T CELL IMMUNOTHERAPY·B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Novartis Pharmaceuticals

KYMRIAH (tisagenlecleucel)

ANTINEOPLASTIC - CAR-T/TCR-T CELL IMMUNOTHERAPY·B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Novartis Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with B-cell acute lymphoblastic leukemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About B-cell acute lymphoblastic leukemia.

B-cell acute lymphoblastic leukemia is an aggressive hematologic malignancy characterized by the uncontrolled proliferation and accumulation of immature B-cell progenitor lymphoblasts within the bone marrow and peripheral blood.

It is the most common subtype of acute lymphoblastic leukemia, predominantly affecting young children while also occurring in adults.

Pathophysiologically, recurring genetic and chromosomal alterations disrupt normal lymphoid differentiation, leading to marrow infiltration and secondary cytopenias that clinically manifest as fatigue from anemia, recurrent infections, and bleeding or bruising from thrombocytopenia, often alongside hepatosplenomegaly, lymphadenopathy, or extramedullary involvement.

Personalize your experience

Follow B-cell acute lymphoblastic leukemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it